June 12, 2017 / 10:59 AM / a month ago

BRIEF-Chromadex announces worldwide patent license and research agreement with the Scripps Research Institute

1 Min Read

June 12 (Reuters) - Chromadex Corp

* Chromadex announces an exclusive worldwide patent license and research agreement with the Scripps Research Institute to identify the potential role of Niagen in treating breast cancer

* ‍Has signed a new, exclusive patent license and research agreement with Scripps Research Institute​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below